Follow-up of thrombophilia, inflammation and markers of cardiovascular disease of HIV-1 patients on longterm cART
Completed
- Conditions
- acquired thrombophiliaclotting disoder100644771004743810014523
- Registration Number
- NL-OMON47997
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 39
Inclusion Criteria
Participation in the INF-BEAST study
Exclusion Criteria
No informed consent provided for participation in INF-BEAST2
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Plasma-levels of anti-thrombin, protein C antigen, protein S antigen, free<br /><br>protein S, fibrinogen, lupus anticoagulans, von Willebrand factor antigen,<br /><br>D-dimer</p><br>
- Secondary Outcome Measures
Name Time Method <p>hsCRP, CRP, cholesterol, HDL-, LDL-cholesterol, triglycerides and the<br /><br>occurrence of venous thrombosis and cardiovascular events after almost 8 years<br /><br>of cART. </p><br>